Zeiss Launches Atlas 500 for Ocular Surface Analysis

Zeiss has launched its next-generation corneal topographer, the Atlas 500, a device capable of assessing the cornea for various pathologies.

The Atlas 500 utilizes 24 Placido rings and 6,144 measurement points, with 9.3mm of topographic covering (in 42.2D) and a dioptric range up to 95D, to capture relevant corneal properties with high-resolution images and videos under white and blue light conditions, providing a variety of analysis options including elevation (spheric, aspheric, and aspheric-toric), corneal wavefront, optical quality, contact lens fitting, and more, Zeiss shares.

The imaging and measurement device performs through an interface designed for quick and efficient operation, integrated into both the corneal refractive and cataract workflows, according to Zeiss. Additionally, the device stores images, videos, and reports within its acquisition and analysis software and can link to Zeiss Forum, enabling quicker patient throughput.

zeiss.com  

Novaliq GmbH Announces FDA Approval of Vevye for Treating Dry Eye Disease

Novaliq GmbH announced that the U.S. Food and Drug Administration (FDA) has approved Vevye, a cyclosporine ophthalmic solution for treating the signs and symptoms of dry eye disease.

According to the company, Vevye is cyclosporine solubilized in a water-free excipient. The fast-acting solution was designed to address unmet needs and does not contain water, antimicrobial preservatives, oils, or surfactants, without any associated pH or osmolarity.

Novaliq GmbH shares that Vevye was tested in 738 patients and demonstrated efficacy after four weeks of treatment.

novaliq.com 

Bausch + Lomb Launches Vitamin to Help Support Eye + Heart Health

Bausch + Lomb has launched PreserVision AREDS 2 Formula soft gels with coenzyme Q10 (CoQ10), a vitamin designed to help reduce the risk of progression of moderate to advanced age-related macular degeneration (AMD). CoQ10 is added to support heart health, as heart disease is a top concern for people living with AMD.

Bausch + Lomb shares that PreserVision contains the nutrients recommended by the National Eye Institute, including lutein and zeaxanthin, two antioxidant carotenoids that have been clinically shown to reduce the risk of the progression of AMD in people with moderate to advanced disease.

bausch.com